Status:
COMPLETED
Effect of Tranexamic Acid on Postoperative Bleeding Following Sinus and Nasal Surgery
Lead Sponsor:
Stanford University
Conditions:
Chronic Sinusitis
Nasal Obstruction
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of the research is to assess the effectiveness of a dose of intravenous tranexamic acid (TXA) given intraoperatively to reduce postoperative bleeding after endoscopic sinus or nasal surger...
Eligibility Criteria
Inclusion
- Scheduled to undergo elective sinus or nasal surgery (e.g. septoplasty, inferior turbinate reduction, endoscopic sinus surgery)
- Age 18 or greater
- English-speaking
- Able to provide consent
Exclusion
- Minors (age\<18)
- Pregnant or may become pregnant by time of surgery
- Prisoners
- Non-English speaking
- Foreign citizens
- Unable to provide consent
- Known pro-thrombotic coagulation disorders
- Active intranasal drug use (e.g. cocaine)
- Surgery is for a sinonasal tumor or other sinus pathology not described in inclusion criteria
- Enrollment is in conflict with existing study participation
Key Trial Info
Start Date :
June 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04754230
Start Date
June 17 2021
End Date
February 20 2022
Last Update
April 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305